NCT05200065

Brief Summary

Comparing the peri-operative outcomes in patients with benign prostatic hyperplasia (BPH) who will undergo bipolar enucleation of the prostate versus thulium laser enucleation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 20, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
Last Updated

January 20, 2022

Status Verified

January 1, 2022

Enrollment Period

1.6 years

First QC Date

December 14, 2021

Last Update Submit

January 6, 2022

Conditions

Keywords

Benign Prostatic HyperplasiaThulium laser enucleationBipolar enucleationAnatomic enucleation of the prostateEndoscopic Enucleation of the prostateThulium laserBipolar Plasma energy

Outcome Measures

Primary Outcomes (1)

  • Effect on the operative time and other intra-operative and post-operative parameters

    Effect of the chosen technique on the operative time including both enucleation and morcellation times. The occurrence of any inta-operative complications including significant blood loss necessitating blood transfusion, capsular perforation, sub-trigonal dissection and complications related to morcellation for example bladder perforation. The occurrence of any post-operative complications which is divided into either immediate post-operative and long term complications. Immediate post-operative complications occurring in the first 48 hours after enucleation include affection of the hemodynamics and vital signs of the patient, drop in hemoglobin level, high grade fever or uro-sepsis, retention with re-catheterization, hematuria with clot retention. long term complications occurring include persistent urge or stress urinary incontinence, secondary hemorrhage with hematuria and clot retention, recurrent urinary tract infections, urethral stricture or bladder neck contracture.

    3 to 6 month

Secondary Outcomes (3)

  • Change of the urine flow of the patients.

    3 to 6 month

  • Change of the IPSS (International Prostatic Symptom Score) of the patients

    3 to 6 month

  • Change of residual urine volume after surgery

    3 to 6 month

Study Arms (2)

Thulium Laser Enucleation

EXPERIMENTAL

Patients in this arm will undergo thulium laser enucleation of the prostate.

Procedure: Thulium laser enucleation of the prostate

Bipolar Enucleation

EXPERIMENTAL

Patients in this arm will undergo bipolar enucleation of the prostate.

Procedure: Bipolar enucleation of the prostate

Interventions

Using the thulium laser to achieve complete endoscopic enucleation of the prostate.

Thulium Laser Enucleation

Using the bipolar plasma energy to achieve complete endoscopic enucleation of the prostate.

Bipolar Enucleation

Eligibility Criteria

Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with BPH who are unsatisfied with medical treatment having a Qmax of less than 15 cm/s.
  • Patients with BPH who had refractory retention.
  • Patients with complicated BPH (eg; chronic retention, refractory hematuria, bladder stones).
  • Prostate size of at least 80 grams or more.

You may not qualify if:

  • Patients with a bladder mass.
  • Patients with prostate cancer.
  • Patients suffering from a urethral stricture.
  • Patients with previous endoscopic or surgical prostate intervention.
  • Prostate size less than 80 grams.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr AlAiny School of Medicine

Cairo, 11562, Egypt

RECRUITING

Related Publications (7)

  • Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984 Sep;132(3):474-9. doi: 10.1016/s0022-5347(17)49698-4.

    PMID: 6206240BACKGROUND
  • Gravas S, Bachmann A, Reich O, Roehrborn CG, Gilling PJ, De La Rosette J. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011 Apr;107(7):1030-43. doi: 10.1111/j.1464-410X.2010.09954.x.

    PMID: 21438974BACKGROUND
  • Enikeev D, Glybochko P, Okhunov Z, Alyaev Y, Rapoport L, Tsarichenko D, Enikeev M, Sorokin N, Dymov A, Taratkin M. Retrospective Analysis of Short-Term Outcomes After Monopolar Versus Laser Endoscopic Enucleation of the Prostate: A Single Center Experience. J Endourol. 2018 May;32(5):417-423. doi: 10.1089/end.2017.0898. Epub 2018 Mar 13.

    PMID: 29430969BACKGROUND
  • Scoffone CM, Cracco CM. The en-bloc no-touch holmium laser enucleation of the prostate (HoLEP) technique. World J Urol. 2016 Aug;34(8):1175-81. doi: 10.1007/s00345-015-1741-y. Epub 2015 Dec 11.

    PMID: 26658753BACKGROUND
  • Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol. 2005 Jan-Feb;19(1):25-31. doi: 10.1089/end.2005.19.25.

    PMID: 15735378BACKGROUND
  • Hardy LA, Wilson CR, Irby PB, Fried NM. Thulium fiber laser lithotripsy in an in vitro ureter model. J Biomed Opt. 2014 Dec;19(12):128001. doi: 10.1117/1.JBO.19.12.128001.

    PMID: 25518001BACKGROUND
  • Ryang SH, Ly TH, Tran AV, Oh SJ, Cho SY. Bipolar enucleation of the prostate-step by step. Andrologia. 2020 Sep;52(8):e13631. doi: 10.1111/and.13631. Epub 2020 May 22.

    PMID: 32441397BACKGROUND

MeSH Terms

Conditions

Prostatic Hyperplasia

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Omar AbdelRazzak, MD Urology

    Kasr AlAiny

    STUDY DIRECTOR

Central Study Contacts

Omar AbdelHamid, Msc Urology

CONTACT

Ahmed Ashmawy, MD Urology

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Prospective randomized study comparing the two techniques with patient allocation using computer generated randomization.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective randomized study comparing two techniques of endoscopic enucleation of the prostate.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Urology Cairo University

Study Record Dates

First Submitted

December 14, 2021

First Posted

January 20, 2022

Study Start

January 1, 2021

Primary Completion

July 31, 2022

Study Completion

October 31, 2022

Last Updated

January 20, 2022

Record last verified: 2022-01

Locations